Vuha

🫀Fellow at Cleveland Clinic Florida. IM @ Danbury Hospital/Yale school of medicine.

[Zaid Ansari @Ansari_Zaid7]

New Pub Alert ‼️

Brief Report on safety of colonoscopies in patients on advanced heart failure therapies! ⭐️

https://t.co/k4rjKYtUBM

#GITwitter #cardiotwitter #MedTwitter

@CleveClinicFL @TolgaErim @AsadurRahman87 @OsamaSherjeel @vuhareddi @tilakshahmd @JGHofficial

[Cleveland Clinic Florida Cardiology Fellowship @ccflcards]

Excited to welcome our incredible new cardiology fellows! 💖 We can’t wait to grow, learn, and make a difference together. Here’s to building a bright future in cardiology! 🚀@CleveClinicFL @CleClinicHVTI @Dr_Snips @FScottRossMD @JoseNaviaMD @JerryEstepMD

[Eugene Yang @DrEugeneYang]

Excited for #ACCAsia to begin in Delhi, India ⁦@CathieBiga⁩ ⁦@ChrisKramerMD⁩ ⁦⁦@kwanleemd⁩ ⁦@ACCinTouch⁩

[JAMA @JAMA_current]

Narrative review explores how to manage use of DOACs—apixaban, rivaroxaban, edoxaban, and dabigatran—in patients undergoing surgical and nonsurgical procedures to decrease risks of bleeding and thromboembolism. https://t.co/nBo8ESxMDG

[Eric H Yang, MD @datsunian]

🙏 to @FloridaACC @DSadlerMD for the generous invite to speak on ICI toxicities for the general ❤️ HCP & hearing some great cases! (…& having fun at @WaltDisneyWorld was 👍)

Immunotherapy ❤️ TOX is a dynamic & relevant field for not just #cardioonc for cardiology as a whole!

[Diego Sadler MD FACC @DSadlerMD]

Thank you @vuhareddi @mealomar @daehyunleemd for your great presentations during our @FloridaACC cardio-oncology breakout session! Many thanks to @datsunian and @drbrowncares for your contributions @ACCinTouch @ICOSociety @CleveClinicFL @Cancer_CCFla @JerryEstepMD @CCFloridaEP

[Vuha @vuhareddi]

@AntonioLewisMD @CCFloridaEP @CleveClinicFL @HeartVasc_CCFla Congratulations @AntonioLewisMD 🎉🎉

[Vuha @vuhareddi]

I am very lucky to have gotten the opportunity through WIC. @BCSWIC @global_wic @ACCinTouch truly inspires. Its been an amazing 2weeks with lot of cardio-onc learning at @LHCHFT, UK.

@theharveys, you have been so kind, welcoming and encouraging. Thank you so much!

#WICcollab

[Akshay Machanahalli Balakrishna, MD @Dr_Akshay_MB]

Excited to share our review on intermediate risk PE, the gray area in which there is uncertainty regarding therapeutic approach.
https://t.co/uMeWjFG6Dd
Thanks to my mentor @SarasVallabhMD for the constant support.
Thank you @vuhareddi @TweetingHeartMD @wissamj123
@IMCreighton

[Saraschandra Vallabhajosyula, MD MSc @SarasVallabhMD]

Read our invited review on #IntermediateRisk #PulmonaryEmbolism published today in @MDPIOpenAccess Medicina - https://t.co/9h1LPWfuc9. Kudos to @Dr_Akshay_MB and @vuhareddi for leading this. @TweetingHeartMD @wissamj123 @wakeforestmed @WFCardiology @AtriumHealthWFB @WakeForestCCM

[Vuha @vuhareddi]

@SarasVallabhMD @MDPIOpenAccess @Dr_Akshay_MB @TweetingHeartMD @wissamj123 @wakeforestmed @WFCardiology @AtriumHealthWFB @WakeForestCCM This is not possible without you. Thank you so much for your constant support Dr. Vallabhajoysula.

[Vuha @vuhareddi]

@HFnursemaghee @ACCinTouch @DrQuinnCapers4 @melsulistio @MelvinEchols9 @RannaParekh Thank you for all you do ♥️

[Maghee Disch RN, MSN, CHFN, FHFSA, AACC @HFnursemaghee]

Just finished up the better part of my Friday pairing over 250 Residents w/mentors @ACCinTouch & it's members are invested in changing #TheFaceOfCardiology we can't wait to see our mentors & mentees at #ACC22 #ACCDiversity @DrQuinnCapers4 @melsulistio @MelvinEchols9 @RannaParekh

[Joseph Marine @DrJMarine]

@ACCinTouch Internal Medicine/Cardiology Pipeline Program today. The future of cardiology is bright! #TheFaceofCardiology #ACCWIC @drmalissawood @MinnowWalsh @melsulistio @sandylewis @apmille1 @HFnursemaghee @ditchhaporia @GarimaVSharmaMD @DrToniyaSingh @gina_lundberg

[Quinn Capers, IV @DrQuinnCapers4]

File this under “Epic.”

Over 100 Women IM residents who aspire to be cardiologists on a call with some of the nation’s foremost women cardiologists. Courtesy of ⁦@ACCinTouch⁩’s #Diversity Committee. Only 13% of cardiologists are women. But the future is bright. Join us!